Tevogen (TVGN) Net Shares Issued and Repurchased (2023 - 2024)
Tevogen's (TVGN) quarterly Net Shares Issued and Repurchased came in at $120000.0 in Q4 2024, up 430.36% on a YoY basis from $22626.0 in Q1 2024, and down 99.7% quarter-over-quarter from $40.0 million in Q1 2024.
Powered by 
Analysis
Tevogen (TVGN) Net Shares Issued and Repurchased (2023 - 2024) Analysis & Trends
Tevogen (TVGN) has reported Net Shares Issued and Repurchased for 2 consecutive years, with $120000.0 the latest figure, recorded in Q4 2024.
- For the quarter ending Q4 2024, Net Shares Issued and Repurchased rose 430.36% year-over-year to $120000.0; the trailing twelve-month figure through Dec 2024 stood at $120000.0 (up 430.36% YoY), and the FY2024 full-year result was $120000.0, up 430.36% from the prior year.
- Net Shares Issued and Repurchased slipped to $120000.0 in Q4 2024 per TVGN's latest filing, from $40.0 million in the prior quarter.
- Across five years, Net Shares Issued and Repurchased topped out at $40.0 million in Q1 2024 and bottomed at $22626.0 in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.37 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.36 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn | - |
| 5 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | - |
| 10 | Tevogen | 27.76 Mn | 27.76 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 120,000.00 |
| Mar 31, 2024 | 40.00 Mn |
| Dec 31, 2023 | 22,626.00 |